ALOMIDE

This brand name is authorized in United States. It is also authorized in Canada, Finland, South Africa, Turkey.

Active ingredients

The drug ALOMIDE contains one active pharmaceutical ingredient (API):

1	Lodoxamide UNII 50LV9A548L - LODOXAMIDE TROMETHAMINE
	Lodoxamide is a mast cell stabiliser that inhibits the in vivo Type I immediate hypersensitivity reaction in animals and man.
	Read more about Lodoxamide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ALOMIDE Eye drops, solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01GX05	Lodoxamide	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00893560
FI	Lääkealan turvallisuus- ja kehittämiskeskus	469494
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504612011
US	FDA, National Drug Code	0065-0345
ZA	Health Products Regulatory Authority	X/15.4/26